Phenotypic Consequences of
ABCB1
drug resistance
high-grade serous ovarian cancer
high-throughput drug screening
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
11 Nov 2021
11 Nov 2021
Historique:
received:
28
09
2021
revised:
05
11
2021
accepted:
05
11
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
28
11
2021
Statut:
epublish
Résumé
Despite high response rates to initial chemotherapy, the majority of women diagnosed with High-Grade Serous Ovarian Cancer (HGSOC) ultimately develop drug resistance within 1-2 years of treatment. We previously identified the most common mechanism of acquired resistance in HGSOC to date, transcriptional fusions involving the ATP-binding cassette (ABC) transporter
Identifiants
pubmed: 34830797
pii: cancers13225644
doi: 10.3390/cancers13225644
pmc: PMC8616176
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : National Health and Medical Research Council
ID : APP1124309
Organisme : Victorian Cancer Agency
ID : ECSG15012
Organisme : US National Cancer Institute U54
ID : U54CA209978
Organisme : NHMRC CJ Martin Overseas Biomedical Fellowship
ID : APP1111032
Organisme : Therapeutic Innovation Australia Pipeline Accelerator Grant
Organisme : Cancer Systems Biology Center U54 grant
ID : U54CA209978
Organisme : Cancer Council Victoria
ID : APP1184894
Organisme : NHMRC
ID : APP1161198
Références
Nat Rev Cancer. 2015 Nov;15(11):668-79
pubmed: 26493647
Sci Rep. 2015 Jun 12;5:11432
pubmed: 26066708
Cell Res. 2007 Apr;17(4):311-23
pubmed: 17404598
Int J Mol Sci. 2020 May 02;21(9):
pubmed: 32370233
PLoS One. 2015 Jan 30;10(1):e0116747
pubmed: 25635866
Int J Cancer. 2002 Jun 1;99(4):520-8
pubmed: 11992541
Cancer Immun. 2004 Jan 23;4:1
pubmed: 14738373
Biochem Biophys Res Commun. 2008 Aug 1;372(3):440-6
pubmed: 18485890
Sci Data. 2017 Nov 07;4:170166
pubmed: 29112189
Pharmacogenet Genomics. 2011 Mar;21(3):152-61
pubmed: 20216335
Cancers (Basel). 2021 Jan 29;13(3):
pubmed: 33572972
Cancer Res. 2005 Aug 1;65(15):6660-7
pubmed: 16061646
Mol Cell Proteomics. 2012 Apr;11(4):M111.014647
pubmed: 22159717
Pharmacol Rev. 1990 Sep;42(3):155-99
pubmed: 2217530
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Cell. 2000 Nov 22;103(5):757-68
pubmed: 11114332
Med Mol Morphol. 2005 Mar;38(1):2-12
pubmed: 16158173
Nat Rev Drug Discov. 2006 Mar;5(3):219-34
pubmed: 16518375
J Biochem. 2008 Apr;143(4):517-24
pubmed: 18174186
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
Genes Chromosomes Cancer. 1998 Sep;23(1):44-54
pubmed: 9713996
Nature. 2011 Jun 29;474(7353):609-15
pubmed: 21720365
Biol Open. 2017 Jun 15;6(6):723-731
pubmed: 28483980
Lancet. 2021 Jan 23;397(10271):254-256
pubmed: 33485431
Cancer Biol Ther. 2006 Mar;5(3):300-4
pubmed: 16410724
Nature. 2015 May 28;521(7553):489-94
pubmed: 26017449
J Mol Biol. 1999 Oct 22;293(2):381-99
pubmed: 10529352
Cell. 1986 Nov 7;47(3):381-9
pubmed: 2876781
Cell Death Dis. 2011 Jul 07;2:e179
pubmed: 21734725
J Pathol. 2010 May;221(1):49-56
pubmed: 20229506
Cold Spring Harb Perspect Med. 2018 Mar 1;8(3):
pubmed: 28710258
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Crit Rev Oncol Hematol. 2015 Nov;96(2):220-56
pubmed: 26100653
Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4028-33
pubmed: 9108099
J Biol Chem. 1993 Sep 15;268(26):19505-11
pubmed: 8103518
PLoS One. 2016 Nov 3;11(11):e0166058
pubmed: 27812204
J Biol Chem. 2000 Jan 28;275(4):2979-85
pubmed: 10644769
Reprod Biol Endocrinol. 2004 Jan 07;2:4
pubmed: 14711375
Nat Rev Clin Oncol. 2020 Nov;17(11):675-686
pubmed: 32699310
Nat Commun. 2019 Mar 20;10(1):1295
pubmed: 30894541
Nat Protoc. 2012 Apr 05;7(5):839-49
pubmed: 22481527
Cancer Res. 2003 Mar 1;63(5):895-901
pubmed: 12615699
Gynecol Oncol. 2013 Oct;131(1):8-14
pubmed: 23917080
Mol Biol Cell. 2009 Aug;20(15):3598-607
pubmed: 19515834
Biochim Biophys Acta. 1976 Nov 11;455(1):152-62
pubmed: 990323
Biomed Pharmacother. 2020 Nov;131:110718
pubmed: 32932043
Obstet Gynecol. 2017 Mar;129(3):439-447
pubmed: 28178043
Nat Commun. 2019 Apr 3;10(1):1523
pubmed: 30944313
Arch Toxicol. 2021 Jul;95(7):2279-2297
pubmed: 34003341
Endocr Relat Cancer. 2018 May;25(5):R303-R318
pubmed: 29487129
Nat Rev Cancer. 2015 Aug;15(8):473-83
pubmed: 26156638
Cold Spring Harb Perspect Biol. 2012 Jan 01;4(1):a004903
pubmed: 21937732
Lancet Oncol. 2014 Jul;15(8):852-61
pubmed: 24882434
Nat Rev Cancer. 2018 Jul;18(7):452-464
pubmed: 29643473
J Biol Chem. 2015 Dec 4;290(49):29652-62
pubmed: 26468294
Nat Rev Cancer. 2010 Feb;10(2):147-56
pubmed: 20075923
Int J Cancer. 2015 Feb 15;136(4):E188-96
pubmed: 25156304
Int J Breast Cancer. 2011;2011:967419
pubmed: 22332018